BSL2vcvc-lg polypeptides
    22.
    发明授权
    BSL2vcvc-lg polypeptides 有权
    BSL2vcvc-IG多肽

    公开(公告)号:US08674076B2

    公开(公告)日:2014-03-18

    申请号:US13711855

    申请日:2012-12-12

    Abstract: The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

    Abstract translation: 本发明提供编码调节免疫或炎性反应细胞如T细胞活化的B7相关因子的核酸。 还提供了包含编码B7相关多肽(包括BSL1,BSL2和BSL3)的核酸的表达载体和融合构建体。 本发明进一步提供分离的B7相关多肽,分离的包含B7相关多肽的融合蛋白,以及与B7相关多肽特异性反应的抗体或其部分。 此外,本发明提供利用B7相关核酸,多肽或肽的测定法。 本发明还提供可用于人或动物受试者的免疫调节的B7相关核酸,多肽,融合蛋白或抗体的组合物。

Patent Agency Ranking